Press Release
news head

June 24, 2019

BLADDER EPICHECK: Epigenetic urine test for early diagnosis of non-muscle bladder cancer

read more >

Article
news head

June 11, 2019

Diagnostic Predictive Value of the Bladder EpiCheck Test in the Follow-Up of Patients With Non–Muscle-Invasive Bladder Cancer

Bolzano results Cancer Cytopathology 2019

read more >

Press Release
news head

March 25, 2019

Radboud’s Hospital press release

read more >

Press Release
news head

February 24, 2019

New non-invasive bladder cancer test transforms follow-up process

read more >

Press Release
news head

February 24, 2019

Israeli life science innovation on show at prestigious Swiss forum

read more >

Press Release
news head

February 24, 2019

Nucleix’s Non-Invasive Bladder EpiCheck Biomarker Test Allows for Personalized Monitoring of Bladder Cancer

read more >

Article
news head

February 10, 2019

Diagnostic accuracy, clinical utility and influence on decision making of a methylation urine biomarker test in the surveillance of non muscle invasive bladder cancer

read more >

Press Release
news head

January 30, 2019

Nucleix’s Bladder EpiCheck™, Urine Test for Monitoring Bladder Cancer, Chosen as Standard-of-Care by Radboud University Medical Center

read more >

Press Release
news head

January 28, 2019

Nucleix Announces Initial Positive Results in Detection of Upper Tract Urothelial Carcinoma With Its Bladder EpiCheck Urine Test

read more >

Article
news head

January 21, 2019

Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers

read more >